维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="BARTLETT N L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Diagnosis and treatment of Babesia odocoilei in captive reindeer CRangifer tar-andus tarandus ) and recognition of three novel host species显示文摘	Bartlett S L Abou-Madi N Messick I B		I Zoo Wildl Med Z009 400)0，，：	1
2	Brentuximab vedotin (SGN-35) for relapsed CD30-poskive lymphomas显示文摘	Younes A Bartlett N L Leonard J P	2010	N Engl J Med2010，363，19：	1
3	The microbiology of asthma显示文摘	Edwards M R Bartlett N W Hussell T Openshaw P Johnston S L	2012	Nat Rev Microbiol2012，10，：	1
4	Anti-CD30 antibodies for Hodgkin lymphoma显示文摘	Foyil K V Bartlett N L	2010	Curr Hematol Malig Rep2010，5，3：	1
5	Brentux- imab vedotin ( SGN - 35 ) for relapsed CD30 - positive lymphomas 显示文摘	YOUNES A BARTLETT N L LEONARD J P	2010	NEnglJMed2010，363，19：	1
6	Learning the kernel matrix with semidefinite programming 显示文摘	Lanckriet G R G Christianini N Bartlett P L	2004	Journal of Machine Learning Research2004，5，：	1
7	Learning the Kernel Matrix with Semi-definite Programming显示文摘	Lanckriet G Cristianini N Bartlett P L	2004	Journal of Machine Learning Research2004，5，：	1
8	BDNF-induced survival of auditory neurons in vivo:cessation of treatment leads to accelerated loss of survival effects显示文摘	GILLESPIE L N CLARK G M BARTLETT P F	2003	J Neurosci Res2003，71，：	1
9	Quantitativegas chromatography/time-of-flight massspectrometry: A review显示文摘	WILLIAMSON L N BARTLETT M G	2007	Biomedical Chromatography2007，21，7：	1
10	A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30 + hematologic malignancies显示文摘	Bartlett N L Younes A Carabasi M H	2008	Blood2008，111，：	1
11	Brentuximab Vedotin (SGN-35) for relapsed CD30-positive lymphomas 显示文摘	Younes A Bartlett N L Leonard J P	2010	N Engl J Med2010，363，：	1
12	A safety evaluation of brentuximab vedotin for the treatment ofHodgkin lymphoma显示文摘	Oak E Bartlett N L	2016	Expert Opin Drug Saf2016，，：	1
13	A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma 显示文摘	Cheson B D Bartlett N L Vose J M	2012	Cancer2012，118，12：	1
14	A new member of the interleukin 10-related cytokine family encoded by a poxvirus 显示文摘	Bartlett N W Dumoutier L Renaukd J C	2004	J Gen Virol2004，85，：	1
15	Doseescalated cyclophosphamide,doxorubicin,vincristine,prednisone,and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma:Cancer and Leukemia Group B studies 8852 and 8854显示文摘	Bartlett N L Petroni GR Parker BA	2001	Cancer2001，92，2：	1
16	Defining critical roles for NF-KB p65 and type I interferon in innate immunity to rhinovirus显示文摘	Bartlett N W Slater L Glanville N	2012	EMBO Mol Med2012，4，12：	1
17	Learning the kernel matrix with serai-defmite programming 显示文摘	Lanckriet G Cristianini N Bartlett P Gha aui L El Jordan M I	2004	The Journal of Machine Learning Research2004，，5：	1
18	Brentuximab redo tin(SGN--35) for relapsed CD30-Positive lympho mas显示文摘	YOUNES A BARTLETT N L	2010	The New England Journal of Medicine2010，363，：	1
19	Brentuximab vedotin (SGN- 35) for relapsed CD30 -positive lymphomas显示文摘	Younes A Bartlett N L Leonard J P	2010	N Engl J Med2010，363，19：	1
20	A new member of the interleukin 10-related cytokine family encoded by a poxvirus显示文摘	Bartlett N W Dumoutier L Renaukd J C	2004	J Gen Virol2004，85，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示